Vimarsana
Biggest News Aggregation in the World

Approval For News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Approval For. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Approval For Today - Breaking & Trending Today

Incyte Hits Five-Year Low After GSK Snags Approval For A New Jakafi Rival - Vimarsana News

Incyte Hits Five-Year Low After GSK Snags Approval For A New Jakafi Rival

Incyte stock tumbled to a nearly five-year low Monday after GSK gained FDA approval for a rival myelofibrosis treatment. The post Incyte Hits Five-Year Low…

Source: biztoc.com
IMF Gives Approval For $3 Billion Stand-By Arrangement For Pakistan - Vimarsana News

IMF Gives Approval For $3 Billion Stand-By Arrangement For Pakistan

In a relief to the cash-strapped country, International Monetary Fund (IMF) on Wednesday approved a 9-month Stand-By arrangement for Pakistan to support the country's economic stabilization program, Pakistan-based Geo News reported.

Source: ndtv.com
Excellent 12-month results from SELUTION SFA trial presented at JET - Vimarsana News

Excellent 12-month results from SELUTION SFA trial presented at JET

12-month results from the SELUTION SFA trial have been presented at the Japan Endovascular Treatment (JET) Conference in Tokyo. The objective of this study was

China grants conditional approval for Merck's COVID-19 drug - Vimarsana News

China grants conditional approval for Merck's COVID-19 drug

BEIJING, Dec. 30 (Xinhua) -- China has activated special approval procedures and granted conditional approval for the import registration of Merck COVID-19 trea

Serum Institute of India Seeks Centre s Approval For Covid19 Vaccine Covovax As Booster Shot For Adults - Vimarsana News

Serum Institute of India Seeks Centre s Approval For Covid19 Vaccine Covovax As Booster Shot For Adults

Serum Institute of India (SII) seeks Centre's approval for market authorisation of its COVID-19 vaccine, Covovax as a booster dose for those aged 18 years and above.

Source: india.com